Content about Collaborative Care

February 11, 2013

Bartell Drugs has introduced PharmaSmart blood pressure testing kiosks at all 58 of its stores, the regional retail pharmacy chain said Monday.

SEATTLE — Bartell Drugs has introduced PharmaSmart blood-pressure testing kiosks at all 58 of its stores, the regional retail pharmacy chain said Monday.

Bartell said it was the first drug store chain in the Pacific Northwest to provide the new kiosks, made by Rochester, N.Y.-based PharmaSmart International.

February 11, 2013

The Food and Drug Administration declined to approve two insulin products made by Danish drug maker Novo Nordisk, the company said Sunday.

BAGSVÆRD, Denmark — The Food and Drug Administration declined to approve two insulin products made by Danish drug maker Novo Nordisk, the company said Sunday.

Novo Nordisk said it received complete response letters from the FDA for Tresiba (insulin degludec) and Ryzodeg (insulin degludec and insulin aspart). The FDA issues a complete response letter when it has finished reviewing an application for a drug, but determines that the application can't be approved in its current form.

February 11, 2013

Mylan has appointed its president and a former partner at Goldman Sachs to its board of directors, the generic drug maker said.

PITTSBURGH — Mylan has appointed its president and a former Goldman Sachs & Co. partner to its board, the generic drug maker said Monday.

Mylan announced the appointment of president Rajiv Malik and former Goldman Sachs partner Melina Higgins to its board.

February 11, 2013

Generic drug maker Impax Labs has settled with Shire Labs over an authorized generic version of a Shire drug for treating attention deficit hyperactivity disorder, Impax said.

HAYWARD, Calif. — Generic drug maker Impax Labs has settled with Shire Labs over an authorized generic version of a Shire drug for treating attention deficit hyperactivity disorder, Impax said.

February 8, 2013

Elan will sell the rights to its drug for multiple sclerosis to partnering company Biogen Idec for $3.25 billion plus royalties, the Irish drug maker said.

DUBLIN - Elan Corp. will sell the rights to its drug for multiple sclerosis to partnering company Biogen Idec for $3.25 billion plus royalties, the Irish drug maker said.

February 8, 2013

The Food and Drug Administration has approved a generic diabetes drug made by Macleods Pharma, according to agency records.

SILVER SPRING, Md. - The Food and Drug Administration has approved a generic diabetes drug made by Macleods Pharma, according to agency records.

The FDA approved Macleods' pioglitazone hydrochloride tablets in the 15 mg, 30 mg and 45 mg strengths.

The drug is a generic version of Takeda's Actos, branded and generic versions of which had sales of about $2.7 billion during the 12-month period that ended in August 2012, according to IMS Health.

February 8, 2013

The Food and Drug Administration has approved a new drug made by Celgene for treating the cancer multiple myeloma, the agency said Friday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug made by Celgene for treating the cancer multiple myeloma, the agency said Friday.

The FDA announced the approval of Pomalyst (pomalidomide) for patients whose disease has progressed after treatment with other cancer drugs.

February 8, 2013

The Food and Drug Administration has approved a new drug from Warner Chilcott for treating ulcerative colitis, the drug maker said.

DUBLIN — The Food and Drug Administration has approved a new drug from Warner Chilcott for treating ulcerative colitis, the drug maker said.

Warner Chilcott announced the approval of mesalamine in the 400-mg strength.

The company plans to market the drug under the brand name Delzicol and launch it in March.

February 8, 2013

The Food and Drug Administration has given tentative approval to a generic drug for treating hypertension, according to agency records.

 SILVER SPRING, Md. - The Food and Drug Administration has given tentative approval to a generic drug for treating hypertension, according to agency records.

The FDA granted tentative approval to Dr. Reddy's Labs' valsartan tablets in the 40 mg, 80 mg, 160 mg and 320 mg strengths.

The drug is a generic version of Novartis' Diovan. Various versions of the drug had sales of $1.6 billion during the 12-month period that ended in June, according to IMS Health.

February 8, 2013

Biotech drug maker Amgen plans to launch six biosimilar drugs starting in 2017, according to published reports.

NEW YORK — Biotech drug maker Amgen plans to launch six biosimilar drugs starting in 2017, according to published reports.

February 8, 2013

Surprise inspections at 40 compounding pharmacies in Massachusetts last fall have led to 10 being ordered to stop sterile compounding, according to published reports.

NEW YORK - Surprise inspections at 40 compounding pharmacies in Massachusetts last fall have led to 10 being ordered to stop sterile compounding, according to published reports.

State health authorities sent cease-and-desist letters to 11 pharmacies, telling 10 to stop compounding altogether and one to stop compounding the drug sildenafil citrate. Twenty-one other pharmacies were allowed to continue compounding, but were cited for minor violations.

February 8, 2013

President Obama has re-nominated Marilyn Tavenner as administrator of the Centers for Medicare and Medicaid Services, according to published reports.

NEW YORK — President Obama has re-nominated Marilyn Tavenner as administrator of the Centers for Medicare and Medicaid Services, according to published reports.

The Hill, a Washington-based newspaper that covers Capitol Hill, noted that Tavenner had received an endorsement from House majority leader Eric Cantor, R-Va., who had worked with her when she was in charge of the Medicaid program in his state. Still, she could face a tougher time in the Senate.

February 8, 2013

Smoking among adults with mental illnesses is 70% higher than among those without them, according to a new report from the Centers for Disease Control and Prevention.

ATLANTA - Smoking among adults with mental illnesses is 70% higher than among those without them, according to a new report from the Centers for Disease Control and Prevention.

February 8, 2013

Israeli drug maker Taro Pharmaceutical Industries and Indian drug maker Sun Pharmaceutical Industries have terminated their merger agreement, the companies said in a joint statement Friday.

 HAWTHORNE, N.Y. - Israeli drug maker Taro Pharmaceutical Industries and Indian drug maker Sun Pharmaceutical Industries have terminated their merger agreement, the companies said in a joint statement Friday.

Little explanation for the decision to halt the deal was given, except that terminating the agreement was "in the best interest of the respective companies and shareholders." Taro shareholders would have received $39.50 per share upon the closing of the deal.

February 8, 2013

While much of the attention to diabetes has focused on the dramatic rise of Type 2 diabetes among adults and children alike, a new study by a researcher in Philadelphia has found a spike in Type 1 diabetes among children as well.

PHILADELPHIA — While much of the attention to diabetes has focused on the dramatic rise of Type 2 diabetes among adults and children alike, a new study by a researcher in Philadelphia has found a spike in Type 1 diabetes among children as well.

February 8, 2013

An annual event at the Virginia state General Assembly drew several students from a local pharmacy school.

NEW YORK — An annual event at the Virginia state General Assembly drew several students from a local pharmacy school.

Hampton University said 24 of its students visited the General Assembly in Richmond, Va., on Jan. 30 to participate in Virginia Pharmacy Day, organized every year by the Virginia Pharmacist Association. 

The event combined a health fair — with cholesterol, diabetes and blood pressure screenings — and legislative visits with state representatives to discuss pharmacy-related issues.

February 7, 2013

CVS Caremark has announced the extension of its Pharmacy Advisor program to cover an additional five chronic conditions, including asthma, breast cancer, chronic obstructive pulmonary disease, depression and osteoporosis.

WOONSOCKET, R.I. — CVS Caremark has announced the extension of its Pharmacy Advisor program to cover an additional five chronic conditions, including asthma, breast cancer, chronic obstructive pulmonary disease, depression and osteoporosis.

February 7, 2013

Pharmacy automation system manufacturer Innovation has appointed Stephen Donohue as divisional VP sales, chain and high volume, the company said.

JOHNSON CITY, N.Y. — Pharmacy automation system manufacturer Innovation has appointed Stephen Donohue as divisional VP sales, chain and high volume, the company said Thursday.

Innovation, which makes the PharmASSIST automation system, said Donohue would lead all the company's sales and marketing activity for the retail chain, mail order and central fill markets.

February 7, 2013

Kerr Drug will use its partnership with PDX and ScriptPro to increase pharmacy productivity by expanding its central fill model, the regional pharmacy chain said.

RALEIGH, N.C. — Kerr Drug will use its partnership with PDX and ScriptPro to increase pharmacy productivity by expanding its central fill model, the regional pharmacy chain said Thursday.

Kerr announced the opening of its central fill operation in Raleigh, N.C.

"It's not just about labor savings, inventory reductions and other efficiencies," Kerr CEO Tony Civello said. "These kinds of innovations and use of technologies are critical to remaining a player in the emerging healthcare ecosystem."

February 7, 2013

An insomnia drug made by Purdue Pharma "significantly" reduced the time it took patients to return to sleep after they'd woke up in the middle of the night, according to a new study.

STAMFORD, Conn. — An insomnia drug made by Purdue Pharma "significantly" reduced the time it took patients to return to sleep after they'd woke up in the middle of the night, according to a new study.

The placebo-controlled study, published in the journal Sleep, tested the drug Intermezzo (zolpidem tartrate) sublingual tablets on 295 adults with primary insomnia and difficulty returning to sleep after waking up in the middle of the night. Purdue said Intermezzo was the only drug approved by the Food and Drug Administration for treating such patients.

February 7, 2013

Sam's Club will offer free heart health screenings at 563 of its stores on Saturday, the club retailer said.

BENTONVILLE, Ark. — Sam's Club will offer free heart health screenings at 563 of its stores on Saturday, the club retailer said.

The screenings, taking place at stores with pharmacies, will include tests valued at up to $100 for glucose, total cholesterol, high-density lipoprotein cholesterol, blood pressure, body mass index and vision screenings.

February 7, 2013

A survey of community pharmacists suggests that "preferred pharmacy" Medicare Part D drug benefit plans may pose challenges for seniors in rural communities.

ALEXANDRIA, Va. — A survey of community pharmacists suggests that "preferred pharmacy" Medicare Part D drug benefit plans may pose challenges for seniors in rural communities. The finding comes shortly after similar questions were raised at the January public meeting of the Medicare Payment Advisory Commission, Congress' advisory board on Medicare issues, the National Community Pharmacists Association noted Thursday. 

February 7, 2013

A new strain of the bacterium that causes whooping cough immune to vaccines may have appeared in the United States, according to a brief published in the New England Journal of Medicine.

NEW YORK — A new strain of the bacterium that causes whooping cough immune to vaccines may have appeared in the United States, according to a brief published Thursday in the New England Journal of Medicine.

The brief, filed by officials from the Centers for Disease Control and Prevention and other health authorities, reported that a strain of Bordetella pertussis had been reported in Japan, France and Finland and may have appeared in Philadelphia, where 12 children were hospitalized between 2011 and 2012.

February 6, 2013

The Food and Drug Administration has approved a regulatory approval application from Elite Pharmaceuticals for an opioid painkiller, the drug maker said Wednesday.

NORTHVALE, N.J. — The Food and Drug Administration has approved a regulatory approval application from Elite Pharmaceuticals for an opioid painkiller, the drug maker said Wednesday.

Elite announced the FDA approval of its supplemental application for the manufacture and packaging of naltrexone hydrochloride tablets in the 50-mg strength. The company said the approval would allow it to start manufacturing and packaging the drug for its sales and marketing partner, Mikah Pharma, from which it bought rights to the drug in September 2010.

February 6, 2013

The Food and Drug Administration has approved a generic antibiotic made by Sandoz, the drug maker said Wednesday.

PRINCETON, N.J. — The Food and Drug Administration has approved a generic antibiotic made by Sandoz, the drug maker said Wednesday.

Sandoz, the generics arm of Swiss drug maker Novartis, announced the approval and launch of clindamycin in 5% dextrose in minibag form, the first generic version of Pfizer's Cleocin Phosphate in Dextrose 5%.

Sales of the branded version were $52.2 million in 2012, according to IMS Health.